Effects of chlordiazepoxide on footshock- and corticotropin-releasing factor-induced increases in cortical and hypothalamic norepinephrine secretion in rats

Neurochemistry International

Volumn 52, Issue 6, 2008, Pages 1220-1225

  Swiergiel, Artur H ^a,b,c   Li, Yaohui ^d   Wei, Zhong You ^e   Dunn, Adrian J ^a,f  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b INSTITUTE OF GENETICS AND ANIMAL BREEDING   (Poland)

^c UNIVERSITY OF GDA SK   (Poland)

^d Chula Vista Fire Department   (United States)

^e ALCON RESEARCH LTD   (United States)

^f UNIVERSITY OF HAWAII   (United States)

Author keywords

Benzodiazepine; Chlordiazepoxide; Corticotropin releasing factor; Footshock; Norepinephrine; Rat

Indexed keywords

BENZODIAZEPINE; CHLORDIAZEPOXIDE; CORTICOTROPIN RELEASING FACTOR; NORADRENALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN CORTEX; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIALYSATE; FOOTSHOCK; HYPOTHALAMUS; LOCUS CERULEUS; MALE; MICRODIALYSIS; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; STRESS;

ADRENAL CORTEX HORMONES; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; CEREBRAL CORTEX; CHLORDIAZEPOXIDE; CORTICOTROPIN-RELEASING HORMONE; DRUG INTERACTIONS; ELECTRIC STIMULATION; EXTRACELLULAR FLUID; HYPOTHALAMUS; INJECTIONS, INTRAVENTRICULAR; LOCUS COERULEUS; MALE; MICRODIALYSIS; NEURAL PATHWAYS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

RATTUS;

EID: 40949137330     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.01.002     Document Type: Article

References (51)

1. Abercrombie E.D., and Finlay J.M. Monitoring extracellular norepinephrine in brain using in vivo microdialysis and HPLC-EC. In: Robinson T.E., and Justice J.B. (Eds). Microdialysis in the Neurosciences (1991), Elsevier, Amsterdam 253-274
2. Abercrombie E.D., and Jacobs B.L. Systemic naloxone administration potentiates locus coeruleus noradrenergic neuronal activity under stressful but not non-stressful conditions. Brain Res. 441 (1988) 362-366
3. Bremner J.D., Krystal J.H., Southwick S.M., and Charney D.S. Noradrenergic mechanisms in stress and anxiety. I. Preclinical studies. Synapse 23 (1996) 28-38
4. Bremner J.D., Krystal J.H., Southwick S.M., and Charney D.S. Noradrenergic mechanisms in stress and anxiety. II. Clinical studies. Synapse 23 (1996) 39-51
5. Britton K.T., Lee G., Vale W., Rivier J., and Koob G.F. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat. Brain Res. 369 (1986) 303-306
6. Butler P.D., Weiss J.M., Stout J.C., and Nemeroff C.B. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J. Neurosci. 10 (1990) 176-183
7. Charney D.S., Grillon C.C.G., and Bremner J.D. The neurobiological basis of anxiety and fear: circuits, mechanisms, and neurochemical interactions. Part II. Neuroscience 4 (1998) 122-132
8. Charney D.S., Heninger G.R., and Redmond D.E. Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci. 33 (1983) 19-29
9. Dennis T., L'Heureux R., Carter C., and Scatton B. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat. J. Pharmacol. Exp. Ther. 241 (1987) 642-649
10. Deroche V., Piazza P.V., Casolini P., Maccari S., Lemoal M., and Simon H. Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion. Brain Res. 598 (1992) 343-348
11. Dunn A.J. Changes in cerebral dopamine, norepinephrine, and serotonin metabolism during stress and following CRF administration. In: Van Loon G.R., Kvetnansky R., McCarty R., and Axelrod J. (Eds). Stress: Neurochemical and Humoral Mechanisms (1989), Gordon & Breach, New York 79-97
12. Dunn A.J., and Berridge C.W. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems. Pharmacol. Biochem. Behav. 27 (1987) 685-691
13. Dunn A.J., and Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?. Brain Res. Rev. 15 (1990) 71-100
14. Foote S.L., Bloom F.E., and Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol. Rev. 63 (1983) 844-914
15. Glavin G.B. Stress and brain noradrenaline: a review. Neurosci. Biobehav. Rev. 9 (1985) 233-243
16. Gorman A.L., Dunn A.J., and Goeders N.E. A corticotropin-releasing factor (CRF) antagonist attenuates cocaine-induced defensive withdrawal. Pharmacologist 34 (1992) 208
17. Grant S.J., Huang Y.H., and Redmond D.E. Benzodiazepines attenuate single unit activity in the locus coeruleus. Life Sci. 27 (1980) 2231-2236
18. Harary N., and Kellogg C. The relationship of benzodiazepine binding sites to the norepinephrine projection in the hypothalamus of the adult rat. Brain Res. 492 (1989) 293-299
19. Ida Y., Tanaka M., Tsuda A., Tsujimaru S., and Nagasaki N. Attenuating effect of diazepam on stress-induced increases in noradrenaline turnover in specific brain regions of rats: antagonism by Ro 15-1788. Life Sci. 37 (1985) 2491-2498
20. Imaki T., Wang X.Q., Shibasaki T., Harada S., Chikada N., Takahashi C., Naruse M., and Demura H. Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN). Mol. Brain Res. 32 (1995) 261-270
21. Irwin J., Ahluwalia P., and Anisman H. Sensitization of norepinephrine activity following acute and chronic stress. Brain Res. 379 (1986) 98-103
22. Kalin N.H., Sherman J.E., and Takahashi L.K. Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats. Brain Res. 457 (1988) 130-135
23. Kalin N.H., and Takahashi L.K. Fear-motivated behavior induced by prior shock experience is mediated by corticotropin-releasing hormone systems. Brain Res. 509 (1990) 80-84
24. Kalivas P.W., Richardson-Carlson R., and Van Orden G. Cross-sensitization between foot shock stress and enkephalin-induced motor activity. Biol. Psychiat. 21 (1986) 939-950
25. Lavicky J., and Dunn A.J. CRF administration increases extracellular concentrations of noradrenaline and dopamine. J. Psychopharmacol. (1992) A89
26. Lavicky J., and Dunn A.J. Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J. Neurochem. 60 (1993) 602-612
27. Lee E.H.Y., Chang S.Y., and Chen A.Y.J. CRF facilitates NE release from the hippocampus: a microdialysis study. Neurosci. Res. 19 (1994) 327-330
28. Palamarchouk V.S., Swiergiel A.H., and Dunn A.J. Hippocampal noradrenergic responses to CRF injected into the locus coeruleus of unanesthetized rats. Brain Res. 950 (2002) 31-38
29. Palamarchouk V.S., Zhang J.-J., Zhou G., Swiergiel A.H., and Dunn A.J. Hippocampal norepinephrine-like voltammetric responses to infusion of corticotropin-releasing factor into the locus coeruleus. Brain Res. Bull. 51 (2000) 319-326
30. Pardon M.-C., Gould G.G., Garcia A., Phillips A., Cook M.C., Miller S.A., Mason P.A., and Morilak D.A. Stress reactivity of the brain noradrenergic system in three rat strains differing in their neuroendocrine and behavioral responses to stress: implications for susceptibility to stress-related neuropsychiatric disorders. Neuroscientist 115 (2002) 229-242
31. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, San Diego, CA
32. Rasmussen K., and Jacobs B.L. Single unit activity of locus coeruleus neurons in the freely moving cat. II. Conditioning and pharmacologic studies. Brain Res. 371 (1986) 335-344
33. Redmond D.E. The possible role of locus coeruleus noradrenergic activity in anxiety-panic. Clin. Neuropharmacol. 9 (1986) S16-40-42
34. Robinson T.E., Angus A.L., and Becker J.B. Sensitization to stress: the enduring effects of prior stress on amphetamine-induced rotational behavior. Life Sci. 37 (1985) 1039-1042
35. Rossetti Z.L., Portas C., Pani L., Carboni S., and Gessa G.L. Stress increases noradrenaline release in the rat frontal cortex: prevention by diazepam. Eur. J. Pharmacol. 176 (1990) 229-231
36. Roth K.A., and Katz R.A.J. Stress, behavioral arousal, and open field activity-a reexamination of emotionality in the rat. Neurosci. Biobehav. Rev. 3 (1979) 247-263
37. Rybarczyk M.C., Orosco M., Rouch C., Jacquot C., and Cohen Y. Interaction of cholecystokinin and diazepam: effects on brain monoamines. Fund. Clin. Pharmacol. 4 (1990) 245-253
38. Sherman J.E., and Kalin N.H. ICV-CRH alters stress-induced freezing behavior without affecting pain sensitivity. Pharmacol. Biochem. Behav. 30 (1988) 801-807
39. Simson P.E., and Weiss J.M. Peripheral, but not local or intracerebroventricular, administration of benzodiazepines attenuates evoked activity of locus coeruleus neurons. Brain Res. 490 (1989) 236-242
40. Smagin G.N., Swiergiel A.H., and Dunn A.J. Corticotropin-releasing factor administered into the locus coeruleus, but not the parabrachial nucleus, stimulates norepinephrine release in the prefrontal cortex. Brain Res. Bull. 36 (1994) 71-76
41. Smagin G.N., Swiergiel A.H., and Dunn A.J. Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in rat hypothalamus: comparison with plasma corticosterone. Psychoneuroendocrinology 21 (1996) 83-93
42. Swiergiel A.H., Takahashi L.K., and Kalin N.H. Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat. Brain Res. 623 (1993) 229-234
43. Swiergiel A.H., Takahashi L.K., Rubin W.W., and Kalin N.H. Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats. Brain Res. 587 (1992) 263-268
44. 2 receptors in fear and anxiety. Neurosci. Biobehav. Rev. 25 (2001) 627-636
45. 2 receptors produces anxiolytic behavior in animal models of anxiety. Brain Res. 902 (2001) 135-142
46. Takahashi L.K., Kalin N.H., and Baker E.W. Corticotropin-releasing factor antagonist attenuates defensive-withdrawal behavior elicited by odors of stressed conspecifics. Behav. Neurosci. 104 (1990) 386-389
47. Torda T., Yamaguchi I., Hirata F., Kopin I.J., and Axelrod J. Mepacrine treatment prevents immobilization-induced desensitization of B-adrenergic receptors in rat hypothalamus and brain stem. Brain Res. 205 (1981) 441-444
48. Weiss J.M., Simson P.E., Knight J.A., and Kilts C.D. Hyperresponsivity of locus coeruleus is associated with stress-induced behavioral depression. Soc. Neurosci. Abstr. 13 (1987) 32
49. 1-adrenergic receptors are involved in CRF-induced defensive-withdrawal. Pharmacol. Biochem. Behav. 36 (1990) 847-851
50. Yokoo H., Tanaka M., Yoshida M., Tsuda A., Tanaka T., and Mizoguchi K. Direct evidence of conditioned fear-elicited enhancement of noradrenaline release in the rat hypothalamus assessed by intracranial microdialysis. Brain Res. 536 (1990) 305-308
51. Zhang J.-J., Swiergiel A.H., Palamarchouk V.S., and Dunn A.J. Intracerebroventricular infusion of CRF increases extracellular concentrations of norepinephrine in the hippocampus and cortex as determined by in vivo voltammetry. Brain Res. Bull. 47 (1998) 227-284